{"id":2171,"date":"2010-07-01T12:07:00","date_gmt":"2010-07-01T10:07:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2010\/co-trimoxazol-erhoeht-das-blutungsrisiko-unter-oraler-antikoagulation"},"modified":"2022-03-17T14:11:53","modified_gmt":"2022-03-17T13:11:53","slug":"co-trimoxazol-erhoeht-das-blutungsrisiko-unter-oraler-antikoagulation","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2010\/co-trimoxazol-erhoeht-das-blutungsrisiko-unter-oraler-antikoagulation","title":{"rendered":"Co-trimoxazol erh\u00f6ht das Blutungsrisiko unter oraler Antikoagulation"},"content":{"rendered":"<p>Potenziell k\u00f6nnen viele Arzneimittel \u00fcber eine Induktion bzw. Inhibition CYP450-abh\u00e4ngiger Enzyme die Wirkung einer oralen Antikoagulation (OAK) mit Vitamin-K-Antagonisten beeinflussen. Informationen \u00fcber klinisch relevante Interaktionen sind aber meist Einzelfall-Berichte von unterschiedlicher Qualit\u00e4t. Systematische Untersuchungen gibt es nur sehr wenige. Eine aktuell in den Arch. Intern. Med. publizierte Untersuchung liefert nun erstmals Hinweise auf eine klinisch [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Potenziell k\u00f6nnen viele Arzneimittel \u00fcber eine Induktion bzw. Inhibition CYP450-abh\u00e4ngiger Enzyme die Wirkung einer oralen Antikoagulation (OAK) mit Vitamin-K-Antagonisten beeinflussen. Informationen \u00fcber klinisch relevante Interaktionen sind aber meist Einzelfall-Berichte von unterschiedlicher Qualit\u00e4t. Systematische Untersuchungen gibt es nur sehr wenige. Eine aktuell in den Arch. Intern. Med. publizierte Untersuchung liefert nun erstmals Hinweise auf eine klinisch [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2590,2592,1426,127,126,137,3173,602,758,452,294,397,604,1692,448,1693,491,1432,289,3174,2625,329,657,646,631,2597,117,4361,138,659,673,1423,667,1035,571,381,378,375,377,4360,1678,1861,136],"class_list":["post-2171","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-5-aminosalizylsaeure","tag-5-asa","tag-alkohol","tag-amiodaron","tag-antiarrhythmika","tag-antikoagulanzien","tag-aethanol","tag-barbiturate","tag-carbamazepin","tag-cholestyramin","tag-ciprofloxacin","tag-citalopram","tag-clofibrat","tag-co-trimoxazol","tag-colestyramin","tag-cotrimoxazol","tag-diltiazem","tag-entacapon","tag-erythromycin","tag-ethanol","tag-fenofibrat","tag-fluconazol","tag-griseofulvin","tag-inh","tag-isoniazid","tag-mesalazin","tag-metronidazol","tag-miconazol","tag-phenprocoumon","tag-phenylbutazon","tag-piroxicam","tag-propafenon","tag-propranolol","tag-ribavirin","tag-rifampicin","tag-selektive-serotonin-wiederaufnahme-hemmer","tag-serotonin-wiederaufnahme-hemmer","tag-sertralin","tag-ssri","tag-sulfinpyrazon","tag-trimethoprim-sulfamethoxazol","tag-voriconazol","tag-warfarin"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2171"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2171\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}